Well, joining me to answer all of those questions and more is my good friend, COVID expert Dr. Eric Topol ... is that once Omicron, and now all of its subsequent variants, lineages that we ...
As with other variants of SARS-CoV-2, XEC is a subvariant of Omicron, and the symptoms of ... risk of severe disease for most people. Dr Eric Topol, a leading voice in COVID research, suggests ...
On the heels of the popular book The Creative Destruction of Medicine by Eric J. Topol, MD, Medscape and Dr. Topol have teamed up to expand on the latest innovations currently influencing the ...
These days, Dr. Eric Topol is perhaps best known for his X account, where he faithfully interprets the latest research on COVID-19 for a following of almost 700,000—including many fellow ...
And welcome to coronavirus in context. My guest today is Dr. Eric Topol, a renowned cardiologist, geneticists, researcher, founder of a research institute at Scripps, and Medscape's editor-in-chief.
“At this juncture, the XEC variant appears to be the most likely one to get legs next,” Dr. Eric Topol ... XEC, according to Topol, is a combination of Omicron sublineages KS.1.1 and KP.3.3 ...
This variant is part of the "Omicron" lineage ... of the Scripps Research Translational Institute, in California, Eric Topol ...
Dear Eric: I am an introvert, my wife is an extrovert, but I was a very involved dad when the kids were little. My wife and I worked full time, and we assumed 50/50 childcare responsibilities.
“At this juncture, the XEC variant appears to be the most likely one to get legs next,” Eric Topol ... taking charge,” Dr Topol said. XEC, a sublineage of the omicron variant, was first ...
Join Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, as they interview experts on the hottest topics in healthcare ranging from COVID-19 to ...
Medscape, October 31, 2023 Physicians: Shape Your AI Future or Someone Else Will Dr Eric Topol discusses the present and future of AI in medicine with historian and futurist Dr Adam Rodman.